SCHEMBL20606960

SCHEMBL20606960

CC(O)Cn1cc(B2OC(C)(C)C(C)(C)O2)c(C(F)(F)F)n1

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 1/20 0.36
▸ NR1H2 P55055 1/20 0.33
▸ NR1H3 Q13133 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30192399 0.83 NR1H2 (0.34) FFAR1NR1H2NR1H3
SCHEMBL24897012 0.83 NR1H2 (0.34) FFAR1NR1H2NR1H3
SCHEMBL20371661 0.82 FFAR1 (0.37) FFAR1
SCHEMBL30154016 0.80 FFAR1 (0.35) FFAR1
SCHEMBL21819814 0.79 FFAR1 (0.35) FFAR1NR1H2NR1H3
SCHEMBL26254927 0.79 KLKB1 (0.37) FFAR1NR1H2NR1H3
SCHEMBL22405990 0.78 FFAR1 (0.34) FFAR1
SCHEMBL21940571 0.77 LRRK2 (0.39) FFAR1
SCHEMBL15723800 0.77 LRRK2 (0.33) FFAR1NR1H2NR1H3
SCHEMBL25239415 0.76 CYP1A2 (0.35) FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3423445-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS GALAPAGOS NV (BE) 2020-04-01 — — EP disclosed
EP-3423445-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS Galapagos NV (BE) 2019-01-09 — — EP disclosed
Send feedback